A review on current nanomaterials and their drug conjugate for targeted breast cancer treatment

References

• MadaniSYNaderiNDissanayakeOTanASeifalianAMA new era of cancer treatment: carbon nanotubes as drug delivery toolsInt J Nanomedicine201162963297922162655
   PubMed Web of Science ®Google Scholar
• WickiAWitzigmannDBalasubramanianVHuwylerJNanomedicine in cancer therapy: challenges, opportunities, and clinical applicationsJ Control Release201520013815725545217
   PubMed Web of Science ®Google Scholar
• DeSantisCSiegelRBandiPJemalABreast cancer statistics, 2011CA Cancer J Clin201161640941821969133
   PubMed Web of Science ®Google Scholar
• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• ProbstCEZrazhevskiyPBagalkotVGaoXQuantum dots as a platform for nanoparticle drug delivery vehicle designAdv Drug Deliv Rev201365570371823000745
   PubMed Web of Science ®Google Scholar
• WangYChenLQuantum dots, lighting up the research and development of nanomedicineNanomedicine20117438540221215327
   PubMed Web of Science ®Google Scholar
• CouvreurPNanoparticles in drug delivery: past, present and futureAdv Drug Deliv Rev2013651212322580334
   PubMed Web of Science ®Google Scholar
• LehnerRWangXMarschSHunzikerPIntelligent nanomaterials for medicine: carrier platforms and targeting strategies in the context of clinical applicationNanomedicine20139674275723434677
   PubMed Web of Science ®Google Scholar
• GrobmyerSRZhouGGutweinLGIwakumaNSharmaPHochwaldSNNanoparticle delivery for metastatic breast cancerMaturitas2012731192622402026
   PubMedGoogle Scholar
• SlamonDJLeyland-JonesBShakSUse of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2N Engl J Med20013441178379211248153
   PubMed Web of Science ®Google Scholar
• Cancerresearch.org [homepage on the Internet]New YorkCancer Research Institute [updated 2016]. Available from: http://www.cancerresearch.org/Cancer-ImmunotherapyAccessed June 28, 2016
   Google Scholar
• Cancer.gov [homepage on the Internet]United States of AmericaNational Institute of Health [updated 2016]. Available from: https://www.cancer.gov/types/breast/patient/breast-treatment-pdqAccessed June 28, 2016
   Google Scholar
• BatraRDaviesJNWheatleyDExtensive arterial and venous thromboembolism with chemotherapy for testicular cancer: a case reportCases J20092908220062719
   PubMedGoogle Scholar
• ChomouckaJDrbohlavovaJHuskaDAdamVKizekRHubalekJMagnetic nanoparticles and targeted drug deliveringPharmacol Res201062214414920149874
   PubMed Web of Science ®Google Scholar
• ChidambaramMManavalanRKathiresanKNanotherapeutics to overcome conventional cancer chemotherapy limitationsJ Pharm Pharm Sci2011141677721501554
   PubMed Web of Science ®Google Scholar
• BikiarisDPapageorgiouGZStergiouAPhysicochemical studies on solid dispersions of poorly water-soluble drugs: evaluation of capabilities and limitations of thermal analysis techniquesThermochim Acta20054391–25867
   Web of Science ®Google Scholar
• LiuBRWiniarzJGMoonJSSynthesis, characterization and applications of carboxylated and polyethylene-glycolated bifunctionalized InP/ZnS quantum dots in cellular internalization mediated by cell-penetrating peptidesColloids Surf B Biointerfaces201311116217023792556
   PubMed Web of Science ®Google Scholar
• YamashitaTYamashitaKNabeshiHCarbon nanomaterials: efficacy and safety for nanomedicineMaterials201252350363
   PubMed Web of Science ®Google Scholar
• BamrungsapSZhaoZChenTNanotechnology in therapeutics: a focus on nanoparticles as a drug delivery systemNanomedicine (Lond)2012781253127122931450
   PubMed Web of Science ®Google Scholar
• BystrovVSBdikinIKHerediaAPiezoelectricity and Ferroelectricity in Biomaterials: From Proteins to Self-assembled Peptide NanotubesCiofaniGMenciassiAPiezoelectric Nanomaterials for Biomedical ApplicationsHeidelbergSpringer2012187
   Google Scholar
• CaoXDengWFuMSeventy-two-hour release formulation of the poorly soluble drug silybin based on porous silica nanoparticles: in vitro release kinetics and in vitro/in vivo correlations in beagle dogsEur J Pharm Sci2013481–2647123123331
   PubMedGoogle Scholar
• GhaffarianRBhowmickTMuroSTransport of Nanocarriers across Gastrointestinal Epithelial cells by a New Transcellular Route Induced by Targeting ICAM-1J Control Release20121631253322698938
   PubMedGoogle Scholar
• ZhangLXueHCaoZKeefeAWangJJiangSMultifunctional and degradable zwitterionic nanogels for targeted delivery, enhanced MR imaging, reduction-sensitive drug release, and renal clearanceBiomaterials201132204604460821453965
   PubMedGoogle Scholar
• NieSUnderstanding and overcoming major barriers in cancer nanomedicineNanomedicine (Lond)20105452352820528447
   PubMed Web of Science ®Google Scholar
• AlexisFPridgenEMLangerRFarokhzadOCNanoparticle technologies for cancer therapyHandb Exp Pharmacol2010197558620217526
   PubMedGoogle Scholar
• ZhangXMengLLuQFeiZDysonPJTargeted delivery and controlled release of doxorubicin to cancer cells using modified single wall carbon nanotubes2009303060416047
   Google Scholar
• HuLTangXCuiFSolid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugsJ Pharm Pharmacol200456121527153515563759
   PubMed Web of Science ®Google Scholar
• AlmeidaAJSoutoESolid lipid nanoparticles as a drug delivery system for peptides and proteinsAdv Drug Deliv Rev200759647849017543416
   PubMed Web of Science ®Google Scholar
• EkambaramPSathaliAAPriyankaKSolid lipid nanoparticles: a reviewSci Revs Chem Commun20122180102
   Google Scholar
• MulikRSMönkkönenJJuvonenROMahadikKRParadkarARTransferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosisInt J Pharm20103981–219020320655375
   PubMed Web of Science ®Google Scholar
• CaraccioloGLiposome-protein corona in a physiological environment: challenges and opportunities for targeted delivery of nanomedicinesNanomedicine201511354355725555353
   PubMed Web of Science ®Google Scholar
• MudshingeSRDeoreABPatilSBhalgatCMNanoparticles: emerging carriers for drug deliverySaudi Pharm J201119312914123960751
   PubMed Web of Science ®Google Scholar
• StoverTKesterMLiposomal delivery enhances short-chain ceramide-induced apoptosis of breast cancer cellsJ Pharmacol Exp Ther2003307246847512975495
   PubMed Web of Science ®Google Scholar
• PrakashSMalhotraMShaoWTomaro-DuchesneauCAbbasiSPolymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer therapyAdv Drug Deliv Rev20116314–151340135121756952
   PubMed Web of Science ®Google Scholar
• YangDYuLVanSClinically relevant anticancer polymer paclitaxel therapeuticsCancers (Basel)201031174224212604
   PubMedGoogle Scholar
• WongHLRauthAMBendayanRA new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cellsPharm Res20062371574158516786442
   PubMed Web of Science ®Google Scholar
• Al FarajAShaikAPShaikASMagnetic single-walled carbon nanotubes as efficient drug delivery nanocarriers in breast cancer murine model: noninvasive monitoring using diffusion-weighted magnetic resonance imaging as sensitive imaging biomarkerInt J Nanomedicine20141015716825565811
   PubMedGoogle Scholar
• KarmakarABrattonSMDervishiEEthylenediamine functionalized-single-walled nanotube (f-SWNT)-assisted in vitro delivery of the oncogene suppressor p53 gene to breast cancer MCF-7 cellsInt J Nanomedicine201161045105521720516
   PubMed Web of Science ®Google Scholar
• XuZPZengQHLuGQYuABInorganic nanoparticles as carriers for efficient cellular deliveryChem Eng Sci200661310271040
   Web of Science ®Google Scholar
• BauerLABirenbaumNSMeyerGJBiological applications of high aspect ratio nanoparticlesJ Mater Chem2004144517526
   Web of Science ®Google Scholar
• HuangHYuanQShahJSMisraRDA new family of folate-decorated and carbon nanotube-mediated drug delivery system: synthesis and drug delivery responseAdv Drug Deliv Rev20116314–151332133921514336
   PubMed Web of Science ®Google Scholar
• SoenenSJRivera-GilPMontenegroJMParakWJDe SmedtSCBraeckmansKCellular toxicity of inorganic nanoparticles: common aspects and guidelines for improved nanotoxicity evaluationNano Today201165446465
   Web of Science ®Google Scholar
• MornetSVasseurSGrassetFDuguetEMagnetic nanoparticle design for medical diagnosis and therapyJ Mater Chem2004141421612175
   Web of Science ®Google Scholar
• FrullanoLMeadeTJMultimodal MRI contrast agentsJ Biol Inorg Chem200712793994917659368
   PubMed Web of Science ®Google Scholar
• PankhurstQAConnollyJJonesSKDobsonJJApplications of magnetic nanoparticles in biomedicineJ Phys D Appl Phys20033613R167R181
   Web of Science ®Google Scholar
• McNeilSENanotechnology for the biologistJ Leukoc Biol200578358559415923216
   PubMed Web of Science ®Google Scholar
• YangJLeeCHParkJAntibody conjugated magnetic PLGA nanoparticles for diagnosis and treatment of breast cancerJ Mater Chem2007172626952699
   Web of Science ®Google Scholar
• ModaniSHKharwadeMENijhawanMOQuantum dots: a novelty of medical field with multiple applicationsInt J Curr Pharm Res2013545559
   Google Scholar
• SekhonBSKambojSRInorganic nanomedicine – part 1Nanomedicine20106451652220417313
   PubMedGoogle Scholar
• YongKTWangYRoyIPreparation of quantum dot/drug nanoparticle formulations for traceable targeted delivery and therapyTheranostics20122768169422896770
   PubMedGoogle Scholar
• SuranaKSinghPKRheeHWBhattacharyaBSynthesis, characterization and application of CdSe quantum dotsJ Ind Eng Chem201420641884193
   Web of Science ®Google Scholar
• ZhuHHuMZShaoLSynthesis and optical properties of thiol functionalized CdSe/ZnS (core/shell) quantum dots by ligand exchangeJ Nanomaterials20142014114
   Google Scholar
• SmithAMDuanHMohsAMNieSBioconjugated quantum dots for in vivo molecular and cellular imagingAdv Drug Deliv Rev200860111226124018495291
   PubMed Web of Science ®Google Scholar
• BradburneCEDelehantyJBBoeneman GemmillKCytotoxicity of quantum dots used for in vitro cellular labeling: role of QD surface ligand, delivery modality, cell type, and direct comparison to organic fluorophoresBioconjug Chem20132491570158323879393
   PubMedGoogle Scholar
• TangYHanSLiuHThe role of surface chemistry in determining in vivo biodistribution and toxicity of CdSe/ZnS core-shell quantum dotsBiomaterials201334348741875523932294
   PubMed Web of Science ®Google Scholar
• ChoiAOBrownSESzyfMMaysingerDQuantum dot-induced epigenetic and genotoxic changes in human breast cancer cellsJ Mol Med200886329130217965848
   PubMed Web of Science ®Google Scholar
• KuzyniakWAdegokeOSekhosanaKSynthesis and characterization of quantum dots designed for biomedical useInt J Pharm20144661–238238924657286
   PubMedGoogle Scholar
• GaneshENSingle walled and multi walled carbon nanotube structure, synthesis and applicationsInt J Innovative Technology Exploring Engineering201324311320
   Google Scholar
• LiuZTabakmanSWelsherKDaiHCarbon nanotubes in biology and medicine: in vitro and in vivo detection, imaging and drug deliveryNano Res2009228512020174481
   PubMed Web of Science ®Google Scholar
• HeisterENevesVTîlmaciuCTriple functionalisation of single-walled carbon nanotubes with doxorubicin, a monoclonal antibody, and a fluorescent marker for targeted cancer therapyCarbon200947921522160
   Web of Science ®Google Scholar
• JiZLinGLuQTargeted therapy of SMMC-7721 liver cancer in vitro and in vivo with carbon nanotubes based drug delivery systemJ Colloid Interface Sci2012365114314921974923
   PubMed Web of Science ®Google Scholar
• PratoMKostarelosKBiancoAFunctionalized carbon nanotubes in drug20084116068
   Google Scholar
• EatemadiADaraeeHKarimkhanlooHCarbon nanotubes: properties, synthesis, purification, and medical applicationsNanoscale Res Lett20149139325170330
   PubMed Web of Science ®Google Scholar
• PanBFCuiDXXuPCellular uptake enhancement of polyamidoamine dendrimer modified single walled carbon nanotubesBiomed Pharma Eng200711316
   Google Scholar
• WebsterDMSundaramPByrneMEInjectable nanomaterials for drug delivery: carriers, targeting moieties, and therapeuticsEur J Pharm Biopharm201384112023313176
   PubMed Web of Science ®Google Scholar
• YezhelyevMVGaoXXingYAl-HajjANieSO’ReganRMEmerging use of nanoparticles in diagnosis and treatment of breast cancerLancet Oncol20067865766716887483
   PubMed Web of Science ®Google Scholar
• HollidayDLSpeirsVChoosing the right cell line for breast cancer researchBreast Cancer Res201113421521884641
   PubMed Web of Science ®Google Scholar
• LigrestiGLibraMMilitelloLBreast cancer: molecular basis and therapeutic strategies (review)Mol Med Rep20081445145821479431
   PubMed Web of Science ®Google Scholar
• TanJMArulselvanPFakuraziSIthninHHusseinMZA review on characterizations and biocompatibility of functionalized carbon nanotubes in drug delivery designJ Nanomater201420141120
   Google Scholar
• MehraNKVermaAKMishraPRJainNKThe cancer targeting potential of D-α-tocopheryl polyethylene glycol 1000 succinate tethered multi walled carbon nanotubesBiomaterials201435154573458824612818
   PubMed Web of Science ®Google Scholar
• KimSYHwangJYSeoJWShinUSProduction of CNT-taxol-embedded PCL microspheres using an ammonium-based room temperature ionic liquid: as a sustained drug delivery systemJ Colloid Interface Sci201544214715325527087
   PubMed Web of Science ®Google Scholar
• AliSBuluwelaLCoombesRCAntiestrogens and their therapeutic applications in breast cancer and other diseasesAnnu Rev Med20116221723221054173
   PubMedGoogle Scholar
• ShenoyDBAmijiMMPoly(ethylene oxide)-modified poly(epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancerInt J Pharm20052931–226127015778064
   PubMed Web of Science ®Google Scholar
• MukherjeeSRaySThakurRSSolid lipid nanoparticles: a modern formulation approach in drug delivery systemIndian J Pharm Sci200971434935820502539
   PubMed Web of Science ®Google Scholar
• FanYZhangQDevelopment of liposomal formulations: from concept to clinical investigationsAsian J Pharm Sci2013828187
   Google Scholar
• LappalainenKJääskeläinenISyrjänenKUrttiASyrjänenSComparison of cell proliferation and toxicity assays using two cationic liposomesPharm Res1994118112711317971713
   PubMed Web of Science ®Google Scholar
• KircheisRSchüllerSBrunnerSPolycation-based DNA complexes for tumor-targeted gene delivery in vivoJ Gene Med19991211112010738575
   PubMed Web of Science ®Google Scholar
• BooserDJEstevaFJRiveraEPhase II study of liposomal annamycin in the treatment of doxorubicin-resistant breast cancerCancer Chemother Pharmacol20025016812111105
   PubMed Web of Science ®Google Scholar
• MadaanASinghPAwasthiAEfficiency and mechanism of intracellular paclitaxel delivery by novel nanopolymer-based tumor-targeted delivery system, Nanoxel(TM)Clin Transl Oncol2013151263222855169
   PubMedGoogle Scholar
• LinGOuyangQHuRIn vivo toxicity assessment of non-cadmium quantum dots in BALB/c miceNanomedicine201511234135025461291
   PubMed Web of Science ®Google Scholar
• CiobotaruCCDamianCMPolosanSProdanaMIovuHDrug delivery study of single-wall carbon nanotubes covalent functionalized with cisplatinDig J Nanomater Biostruct201492859868
   Web of Science ®Google Scholar
• FirmeCP3rdBandaruPRToxicity issues in the application of carbon nanotubes to biological systemsNanomedicine20106224525619699321
   PubMed Web of Science ®Google Scholar
• KangKWChunMKKimODoxorubicin-loaded solid lipid nanoparticles to overcome multidrug resistance in cancer therapyNanomedicine20106221021320060074
   PubMed Web of Science ®Google Scholar
• NgWKSaiful YazanLYapLHWan Nor HafizaWAHowCWAbdullahRThymoquinone-loaded nanostructured lipid carrier exhibited cytotoxicity towards breast cancer cell lines (MDA-MB-231 and MCF-7) and cervical cancer cell lines (HeLa and SiHa)Biomed Res Int2015201526313125632388
   PubMed Web of Science ®Google Scholar
• Doxil^® (doxorubicin hydrochoride liposome injection), for intravenous use [prescribing information]Unites StatesJanssen Products, LP2010
   Google Scholar
• LinYLChenCHWuHYInhibition of breast cancer with transdermal tamoxifen-encapsulated lipoplexJ Nanobiotechnology2016141126892504
   PubMed Web of Science ®Google Scholar
• LiMTagZZhangYLvSLiQChenXTargeted delivery of cisplatin by LHRH-peptide conjugated dextran nanoparticles suppresses breast cancer growth and metastasisActa Biomater20151813214325735801
   PubMed Web of Science ®Google Scholar
• LiMTangZZhangYLHRH-peptide conjugated dextran nanoparticles for targeted delivery of cisplatin to breast cancerJ Mater Chem B201422234903499
   PubMedGoogle Scholar
• Samyang Biopharmaceuticals CorporationGenexol-PM (paclitaxel) Available from: http://www.biokorea.org/upload_2013/download.asp?fn=20130620111137_003228.pdf&fd=TECHAccessed November 29, 2016
   Google Scholar
• Abraxane^® for injectable suspensions (paclitaxel protein-bound particles for injectable suspension) [prescribing information]United StatesCelgene Corporation2015
   Google Scholar
• DingHGangalumPRGalstyanAHER2-positive breast cancer targeting and treatment by a peptide-conjugated mini nanodrugNanomedicine201613263163927520726
   PubMedGoogle Scholar
• DayESBickfordLRSlaterJHRiggallNSDrezekRAWestJLAntibody-conjugated gold-gold sulfide nanoparticles as multifunctional agents for imaging and therapy of breast cancerInt J Nanomedicine2010544545420957166
   PubMed Web of Science ®Google Scholar
• YangDFengLDoughertyCAIn vivo targeting of metastatic breast cancer via tumor vasculature-specific nanographene oxideBiomaterials201610436137127490486
   PubMedGoogle Scholar
• LiuZChenKDavisCDrug delivery with carbon nanotubes for in vivo cancer treatment2008681666526660
   Google Scholar
• PanBCuiDXuPSynthesis and characterization of polyamidoamine dendrimer-coated multi-walled carbon nanotubes and their application in gene delivery systemsNanotechnology2009201212510119420458
   PubMed Web of Science ®Google Scholar